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Abstract
Melatonin has been proposed as a potent anti-oxidant and its presence in many plants and foods 
has been suggested to be beneficial for health. Indeed, the concentrations of melatonin in blood, 
and the melatonin metabolite 6 sulphatoxymelatonin in urine, have been found to increase 
significantly after ingestion of melatonin rich foods. . In this review the studies have been 
critically evaluated in light of the reported plant melatonin concentrations and our knowledge of 
pharmacokinetics of orally administered pure melatonin. In the case of studies involving 
measurement of plasma melatonin following ingestion of beer or fruits the reported increases in 
melatonin are not consistent with the amount of melatonin ingested. Similarly the amount of 
melatonin metabolite excreted following ingestion of melatonin rich foods greatly exceed the 
amount ingested. It is concluded that studies reporting the appearance of melatonin in blood and 
its metabolites in urine following ingestion of melatonin rich foods are flawed. While there may 




Melatonin (N-acetyl 5-methoxy tryptamine) is an indole hormone produced in the pineal gland 
of vertebrates from the amino acid tryptophan. In animals it appears to have many functions, but 
the main ones revolve around the control of reproductive function in many species (Boden, et al., 
2013), including its seasonality (Dardente, 2012) and facilitating the onset of sleep in humans
(Keijzer, et al., 2014). A key feature of its production is that it is primarily produced and secreted 
during darkness, leading to it being called the “hormone of darkness”. During the mid 1990s in 
the USA, melatonin appeared on pharmacy and supermarket shelves as a dietary supplement and 
there was enormous interest in and promotion of its effects as a new drug that could apparently 
prevent aging, cure cancer, improve your sex life, etc. (Pierpaoli & Regelson, 1995). It is still 
available as a supplement in 0.5 - 5 mg doses in the USA, but its sale has always been restricted 
in other jurisdictions. When used as a dietary supplement or as a drug, it is generally taken to 
advance the time of sleep or assist in the recovery from jet lag.
In recent years it has emerged that melatonin is also synthesised in a wide range of plants where 
physiologically it may also have a role as a hormone or as an anti-oxidant (Tan, et al., 2012). In 
animals, melatonin acts on membrane bound G-protein-coupled receptors, designated MT1 and 
MT2 receptors and coded by the MTRN1A and MTRN1B genes (Dubocovich, et al., 2010). 
These are very high affinity receptors with dissociation constants in the low picomolar range.
Endogenous melatonin is metabolised by CYP1A2, sulpho- and glucuronyl-transferase enzymes
(Ma, et al., 2005) in the liver to 6-hydroxymelatonin and 6-sulphatoxy melatonin (aMT.6S) or 6-
glucuronyl melatonin and then excreted. It has been estimated that 90-95% of administered 
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melatonin is excreted as these metabolites (Jones, et al., 1969). An additional potential metabolic 
pathway was proposed to involve oxidation by indoleamine 2,3-dioxygenase giving rise to N1-
acetyl-N2-formyl-5-methoxykynurenamine, which is then de-formylated to N1-acetyl-5-
methoxykynurenamine (Hirata, et al., 1974). In vitro, this transformation can be achieved by 
other enzymes or chemically. Interestingly these metabolites have not been detected in human 
urine following large oral doses (Li, et al., 2013). Nevertheless, melatonin has been proposed to 
be a potent anti-oxidant, protecting cells from reactive oxygen species damage and there have 
been an extraordinary number of studies published on the potential health benefits of this role of 
melatonin, particularly when administered in milligram doses (Reiter, et al., 2010). In this review 
I critically evaluate the evidence that ingestion of melatonin rich foods results in physiologically 
relevant amounts of melatonin being absorbed and distributed throughout the body of humans.
Melatonin in foods 
Since the first report of the detection of melatonin in food (Hattori, et al., 1995), it has been 
measured in a very wide range of plants and plant products. In Table 1 the contents of melatonin 
in selected foods are listed; for more extensive lists see (Huang & Mazza, 2011; Paredes, et al., 
2009). It is clear that measuring melatonin in plants and foods presents important methodological 
issues with respect to recovery and detection of low levels of melatonin. In Table 1 it is clear that 
even for the same type of food, the reported content can vary more than 10 fold between studies. 
In the case of cherry concentrate, one study did not detect melatonin (Kocadagli, et al., 2014)
while another reported 1,420,000 pg/g (Howatson, et al., 2012). (Note that all melatonin 




Oral administration of pure melatonin 
Melatonin has been investigated over many years for its effects on sleep and temperature 
regulation and as a consequence there have been several pharmacokinetic studies of the effects of 
oral administration on plasma concentrations. As summarised recently, the half-life of oral 
administered melatonin is less than 60 minutes and the volume of distribution approximately 
1000L (Peng, et al., 2013). The bioavailability of an oral fast-release preparation has been 
reported to be approximately 15% (DeMuro, et al., 2000; Fourtillan, et al., 2000), with men 
having poorer bioavailability (8.6 ± 3.9%) than women (16.8 ± 12.7% ) (Fourtillan, et al., 2000).
Using this information we can estimate the expected plasma concentration of melatonin 
following oral administration. For example assuming a volume of distribution of 1000 L we 
would predict that ingestion of 1000 μg melatonin would produce a blood level of approximately 
1000 pg/ml; this is very close to the actual peak concentration of melatonin (1354 pg/ml) 
achieved 45 minutes after administration of 1000 μg melatonin to healthy volunteers (Dawson, et 
al., 1996). Using data from the other doses of melatonin administered in that study it is clear that 
there is a dose response relationship between the amount administered and the subsequent peak 
plasma levels (figure 1; (Dawson, et al., 1996)). Furthermore to increase the peak melatonin 
concentration by 5 pg/ml would require the administration of 3.5 μg (3,500,000 pg) melatonin.
Effect of “melatonin rich” food on plasma melatonin 
Does the ingestion of melatonin rich foods lead to physiologically significant changes in plasma 
melatonin? Maldonaldo et al administered 660 ml beer containing 170 pg/ml melatonin to 4 men 
and 330 ml beer to 3 women aged between 20 and 30 years. The amount of melatonin ingested 
was therefore 112 ng for men and 56 ng for women. Blood was drawn before and 45 minutes 
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after consumption of the beer and melatonin was assayed by ELISA. (Maldonado, et al., 2009). 
While the actual average increase in plasma melatonin was not reported, based upon data 
presented in figure 1 of the paper, it can be estimated to be approximately 2.1 pg/ml.
In another study (Sae-Teaw, et al., 2013), blood was collected from subjects before breakfast and 
again after ingestion of either pineapple or orange juice or whole bananas. The estimated intake 
of melatonin was 302 ng, 150 ng and 1.7 ng for pineapple, orange and banana respectively. 
Plasma melatonin analysed by ELISA increased from 32 - 48 pg/ml, 60 minutes after eating the 
fruits to 145 – 151 pg/ml after 120 minutes and then decreased rapidly to be less than 50 pg/ml 
after 180 minutes.
Why are these results difficult to swallow? As previously mentioned, the bioavailability of
melatonin is poor and the volume of distribution is approximately 1000 L. In both of the above 
studies the melatonin intake was between 50 and 300 ng. Following absorption and distribution 
of the oral melatonin, the maximum level that we might expect a 300 ng dose to achieve will be 
300ng/1000 L, i.e., 0.3 pg/ml, well below that reported. Ingestion of approximately 100 times 
less melatonin in the bananas curiously resulted in similar plasma melatonin profiles. Moreover, 
the decrease in plasma melatonin levels between 120 and 180 minutes after ingestion of the fruit 
implies a shorter half life than has been previously reported. It is not known what was measured 
in the plasma melatonin assays, but it is reasonable to suggest that it was not melatonin.
Effect of “melatonin rich” food on melatonin metabolite excretion 
Along with a potential increase in blood levels of melatonin following consumption of melatonin 
rich food, it might be expected that levels of melatonin metabolites would also increase. To 
address this, Oba et al (2008) altered the diet of subjects such that those on a control diet reduced 
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the estimated melatonin intake from 6 selected vegetables from 133 ng to 5 ng per day, while 
those on the intervention diet increased the estimated melatonin intake from 125 ng to 1288 ng 
per day (Oba, et al., 2008). The authors did not indicate when the vegetables were consumed or 
how they were prepared. Overnight first void concentrations of 6-sulphatoxy melatonin 
(aMT.6S) adjusted for creatinine were determined. After 65 days aMT.6S decreased by 4.7 
ng/mg creatinine in the control group (P < 0.05) and increased by 1.5 ng/mg creatinine (P > 0.05) 
in the intervention group. To put this in perspective the following calculations can be made. The 
excretion of creatinine in human urine is approximately 24 mg/kg/24h (Greenblatt, et al., 1976), 
so subjects weighing 50kg will excrete 400 mg creatinine overnight. Therefore it can be 
estimated that the controls in the Oba et al (2008) study decreased their melatonin intake by 128 
ng per day, but decreased aMT.6S excretion by 1880 ng, whereas the intervention group 
increased their melatonin intake by 1163 ng per day and yet only increased aMT.6S by 600 ng. 
Nevertheless the authors concluded that daily consumption of a high amount of selected 
vegetables increased 6-suphatoxymelatonin concentration in first void morning urine.
Jerte Valley cherries are reported to be rich in melatonin. When middle aged and elderly subjects 
consumed 200g of various cherry cultivars twice a day as lunch and dinner deserts the aMT.6S 
content of overnight first void urine was increased by approximately 20 – 80% over baseline 
depending upon the cultivar (Garrido, et al., 2010). If we presume that the average excretion of 
aMT.6S is 30 μg per day (Fellenberg, et al., 1980; Lane & Moss, 1985), this represents an 
increased excretion of 6 – 24 μg aMT.6S per day. The cherries used in this study are reported to 
have a concentration of 0 - 22.4 ng/100g fresh weight (González-Gómez, et al., 2009), which 
represented a daily intake of only 0 to 90 ng melatonin. 
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Studies using similar protocols have been published for a Jerte Valley cherry based product, 
plums and grape juice consumed by young, middle aged and elderly subjects. Consumption of 
the cherry product resulted in 1.5-, 2.4- and 2.5-fold increases in overnight first void aMT.6S 
excretion compared to baseline (Garrido, et al., 2013). Consumption of 195 g plums twice a day 
for 5 days increased overnight excretion of aMT.6S by 2-, 3- and 2-fold in young middle-aged
and elderly participants respectively despite the fact that melatonin “was not quantifiable in the 
plums” (Gonzalez-Flores, et al., 2011). Grape juice (200 ml per day for 5 days) increased 
excretion of aMT.6S by 3-, 3- and 4-fold in the young, middle aged and elderly subjects 
respectively (Gonzalez-Flores, et al., 2012). The amount of melatonin ingested was not reported.
Montmorency cherry juice concentrate or placebo of a fruit cordial containing less than 5% fruit 
were ingested by subjects within 30 of awakening and 30 minutes before the evening meal for 7 
days (Howatson, et al., 2012). Serial urine collections were made over 48 hour periods for the 
interventions and aMT.6S excretion measured. Subjects drinking the cherry concentrate excreted 
approximately 4 μg aMT.6S compared to their baseline while the placebo group did not change. 
Based upon an independent analysis of the melatonin content, the concentrate apparently 
contained 1.42 μg/ml, which equated with a daily intake of approximately 85μg/day.
Finally in a follow-up study of the effects of their previous study on melatonin in fruit, urinary 
aMT.6S excretion was determined following ingestion of juice or pulp from 1 kg pineapple or 
orange and 190 g banana after an evening meal between 1800h and 1830h (Johns, et al., 2012). 
The total urine output from 1900h to 0700h was collected at baseline and the night of fruit 
consumption. Excretion of aMT.6S increased by 180%, 49% and 266% after consumption of 
pineapple, orange and banana respectively. This equates to increases of approximately 54 μg,
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14.7 μg and 79.8 μg aMT.6S following the estimated intake of melatonin of 302 ng, 150 ng and 
1.7 ng for pineapple, orange and banana respectively. 
Why are these results difficult to swallow? The study by Oba et al (2008) seriously overstated 
the outcome of their intervention; when the authors analysed the positive intervention group in 
isolation, increasing the consumption of melatonin 10 fold by ingestion of melatonin rich foods 
did not significantly increase aMT.6S excretion (Oba, et al., 2008). The studies by the University 
of Extramadura group (Garrido, et al., 2013; Garrido, et al., 2010; Gonzalez-Flores, et al., 2012; 
Gonzalez-Flores, et al., 2011) on the effects of cherries, plums and grapes on melatonin 
metabolite excretion reported increases ranging from 6 to 150 μg per day. In other words 
ingestion of melatonin in the order of 100 ng resulted in 60 to 1500 fold increases in metabolite 
excretion in the overnight first void urine. The apparent many fold increases in metabolite are 
probably even larger since the foods were consumed during the afternoon as well as evening and 
the daytime ingestion would not have contributed to the observed overnight metabolite levels. 
Similar assessments can be for the Montmorency cherry (Howatson, et al., 2012) and pineapple, 
orange and banana studies (Johns, et al., 2012). The levels of metabolite excreted do not agree 
with the actual melatonin intake. It should be pointed out also that the concentration of melatonin 
reported in Montmorency cherry juice (Howatson, et al., 2012) is extraordinarily high, being 
approximately 10,000 times higher than previously reported in any food.
The use of urinary excretion of melatonin to support the potential utility of melatonin rich food 
for improving health is in itself curious. There is no question that many of those promoting the 
health benefits of consuming melatonin rich foods propose that the benefits arise from the anti-
oxidant properties of the melatonin. For example in a recent review it was stated that “As an 
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antioxidant, the high levels of melatonin in plants are also beneficial to animals including 
humans, who consume them. Throughout the world, billions of people depend on these products 
as a major food source so the potentially beneficial effects of melatonin consumed in these 
products is obvious” (Tan, et al., 2012). By measuring aMT.6S excretion the researchers are in 
fact determining the amount of melatonin that has escaped oxidation, and instead they are 
measuring melatonin metabolised by CPY1A2. It would be more useful to measure the levels of 
the oxidative products of melatonin such as N1-acetyl-N2-formyl-5-methoxykynurenamine and 
N1-acetyl-5-methoxykynurenamine and/or their further metabolites or conjugates. However, as 
previously mentioned, these metabolites have not been detected even after ingestion of 10 mg 
melatonin (Li, et al., 2013).
What are the possible explanations for the detection of melatonin and its metabolites? 
There are several possibilities that might explain the results that have been reported regarding the 
ingestion of melatonin rich foods. The foods may contain precursors of melatonin such as 
tryptophan or 5-hydroxy tryptophan which are then converted to melatonin. In a study involving 
the intra venous infusion of 5 grams of tryptophan over 40 minutes during daytime, the plasma
melatonin concentration increased to 290 pg/ml, 60 minutes after the start of the infusion and
then decreased to the expected low daytime levels after 5 hours (Heuther, et al., 1992). In another 
study, subjects ingested 6 grams of tryptophan and plasma melatonin levels increased 
approximately 12 pg/ml after five hours (Christofides, et al., 2006). In the case of oral 
administration of 600 – 800 mg 5-hydroxy tryptophan, plasma melatonin levels did not increase 
above the detection limit of 15.6 pg/ml (Cavallo, et al., 1987). It is thus unlikely that melatonin 
precursors are responsible for the reported melatonin increases.
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The melatonin rich foods may contain CYP1A2 inhibitors which delay/prevent the metabolism 
of endogenous melatonin, leading to elevated plasma melatonin. It is known for example that 
certain foods, like carrots, celeriac, celery, coriander, cumin, grapefruit juice, parsnip and parsley 
may inhibit CYP1A2 (Perera, et al., 2012). The opposite argument would be required for studies 
that resulted in the many fold increases in melatonin metabolite excretion following ingestion of 
melatonin rich foods. While I am not aware of studies addressing the effects of the melatonin 
rich foods on CYP1A2 activity, if they did have significant activity, the overall health 
consequences for people taking drugs that are metabolised by CYP1A2 would be of major 
concern.
Finally the assays used to measure the plasma melatonin and urinary aMT.6S levels may not be 
specific for their target analytes and instead they may be detecting other interfering compounds 
that are perhaps related indoles, for example “melatonin isomers” (Gomez, et al., 2013; 
Kocadagli, et al., 2014) or unrelated compounds.
Conclusion 
Melatonin is a remarkable compound that is found across plant and animals species in ng/g 
concentrations or lower. By virtue of studies in animals demonstrating anti-oxidant properties of 
endogenous and exogenous melatonin, a view has emerged that the melatonin in plants used as 
food may have beneficial health effects in humans. Studies reporting the appearance of 
melatonin in blood and its metabolites in urine following ingestion of melatonin rich foods 
appear to be flawed. The known pharmacokinetic profile of melatonin following its oral 
administration do not support the large changes that have been reported in the literature, which in 
some cases represent 5 fold increases in metabolite excretion over the endogenous production. 
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While there may be health benefits of ingestion of certain foods it is difficult to accept that they 
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Table 1. Concentration of melatonin in various foods. Data are shown as pg/g or pg/ml.
Food Melatonin concentration Reference
Walnut 137 pg/g (Kocadagli, et al., 2014)
Walnut 3400 pg/g (Reiter, et al., 2005)
Orange juice 2500 pg/ml (Fernández-Pachón, et al., 2014)
Orange 150 pg/g (Johns, et al., 2012)
Banana 8.9 pg/g (Johns, et al., 2012)
Banana Not Detected (Huang & Mazza, 2011)
Banana 655 pg/g (Badria, 2002)
Banana 470 pg/g (Dubbels, et al., 1995)
Pineapple 302 pg/g (Johns, et al., 2012)
Pineapple 280 pg/g (Badria, 2002)
Pineapple 40 pg/ml (Hattori, et al., 1995)
Sour cherry concentrate <17.2 pg/ml (Kocadagli, et al., 2014)
Sour cherry concentrate 1,420,000 pg/ml (Howatson, et al., 2012)
Merlot Not Detected (Gomez, et al., 2013)
Mid strength beer 113 pg/ml (Garcia-Moreno, et al., 2013)
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 20
Figure 1 Peak plasma melatonin concentration following the oral ingestion of 100 μg, 500 μg, 
1000 μg and 5000 μg melatonin using data from (Dawson, et al., 1996). The insert shows the 
data between 0 and 30 μg melatonin. From this it can be estimated that to achieve a 5 pg/ml 
increase in melatonin, approximately 3.5 μg would need to be consumed.
